CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		44,618,357
Beginning balance at Dec. 31, 2021	$ 635,180	$ 4	$ 777,074	$ (1,382)	$ (140,516)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of options (in shares)		8,283
Common stock issued upon exercise of options	75		75
Issuance of common stock for vesting of restricted stock units (in shares)		818,489
Issuance of common stock for vesting of stock awards	1	$ 1
Shares withheld for payroll taxes related to vesting of restricted stock units (in shares)		(247,979)
Shares repurchased for withholding tax on stock awards	(2,461)		(2,461)
Issuance of common stock under cashless warrant exercise (in shares)		99
Stock-based compensation expense	8,354		8,354
Net loss	(285,415)				(285,415)
Foreign currency translation gain (loss)	$ (5,853)			(5,853)
Ending balance (in shares) at Dec. 31, 2022	45,197,249	45,197,249
Ending balance at Dec. 31, 2022	$ 349,881	$ 5	783,042	(7,235)	(425,931)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for vesting of restricted stock units (in shares)		805,306
Shares withheld for payroll taxes related to vesting of restricted stock units (in shares)		(212,665)
Shares repurchased for withholding tax on stock awards	(271)		(271)
Stock-based compensation expense	5,075		5,075
Net loss	(64,813)				(64,813)
Foreign currency translation gain (loss)	$ 738			738
Ending balance (in shares) at Dec. 31, 2023	45,789,890	45,789,890
Ending balance at Dec. 31, 2023	$ 290,610	$ 5	$ 787,846	$ (6,497)	$ (490,744)